Plain-English translation of NCT02118467 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
When patients are critically ill and have very low blood pressure (a condition called shock), doctors use medications called vasopressors to help raise blood pressure and get blood flowing to vital organs. This trial compares two different pairs of vasopressor medications: with versus with . The study is testing whether one pair causes fewer heart rhythm problems than the other.
Doctors currently choose between these medications based on personal preference rather than solid evidence about which works best. Recent research suggests that medications causing faster heart rates may lead to dangerous heart rhythms and worse outcomes, so this study will help determine whether the medication pair that keeps heart rate lower is actually safer and more effective.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive one of the two medication combinations through a central IV line in the intensive care unit. The medications will be given as continuous infusions, with doses adjusted by your care team based on your blood pressure and response. A research pharmacist will prepare the medications so that neither you nor your doctors know which pair you're receiving, ensuring an unbiased comparison. Your heart rhythm, blood pressure, and other vital signs will be closely monitored throughout your ICU stay.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States